Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A pathway helps maintain long telomeres in both stem and cancer cells.

Acitretin effectively prevented skin cancer in a patient with late-onset Rothmund-Thomson syndrome.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Clonally expanded CD8+ T cells cause alopecia areata.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

CRABP1 boosts hair cell growth in Hu sheep by affecting key genes.

Adrenal tumors can cause high progesterone levels, mimicking symptoms of high cortisol.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

A 69-year-old woman has a fast-growing hand lesion that didn't improve with salicylic acid.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Antioxidants can block the cancer-fighting effects of doxorubicin.

New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

A new genetic tool improves the study of hair growth and potential hair disorder treatments.

CRH causes hair loss by reducing cell survival in hair follicles.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Modified β-catenin can cause different effects in mouse skin cells, leading to cysts or tumors depending on the cell type.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Overexpressing IGF-1 in mice leads to skin abnormalities and tumors.